Description
Participants will explore how the integration of digital pathology and artificial intelligence (AI) is transforming pathology diagnostics and biomarker testing workflows. The session will review recent technological advances in digital pathology, including innovative imaging platforms, workflow optimization, and AI-based diagnostic algorithms. Additionally, attendees will understand the potential benefits and current limitations of AI-driven diagnostics in pathology practice, enabling informed planning and decision-making.
Release Date
May 29, 2025
12 pm to 1 pm Eastern Time
Faculty
Marilyn Bui, MD, PhD
Senior Member, Departments of Pathology and Machine Learning
Scientific Director of Analytic Microscopy Core
Moffitt Cancer Center & Research Institute
Professor, Department of Oncological Sciences
University of South Florida (USF) Morsani College of Medicine
Target Audience
This program is designed for pathologists.
Learning Objectives
At the conclusion of this activity, learners should be better able to:
- Explore the integration of digital pathology and artificial intelligence (AI) in enhancing pathology diagnostics and biomarker testing.
- Review recent advances in digital pathology.
- Discuss the potential and limitations of AI-driven diagnostics in pathology practice.
Support Statement
Support for this accredited continuing education activity has been made possible through educational grants from AstraZeneca and Daiichi Sankyo.
Accreditation and Credit Designation
In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and Florida Society of Pathologists (FSP). American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
American Academy of CME, Inc., designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
Other members of the care team will receive a certificate of participation.
How to Participate in this Activity and Obtain CME Credit
There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the program evaluation.
Disclosures
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers, and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.
Faculty/Planner:
Marilyn Bui, MD, PhD – Florida Society of Pathologists: Discloses the following relevant financial relationships:
Advisory Board/Consultant: Visiopharm, Aiforia, Roche, AstraZeneca, PathAI, DigitCells, Merck.
Planners:
John JD Juchniewicz, MCIS, CHCP, FACEHP - American Academy of CME: No relevant financial relationships with ineligible companies to disclose.
Erin Corrales - Florida Society of Pathologists: No relevant financial relationships with ineligible companies to disclose.
Joseph Kim, MD – Florida Society of Pathologists: No relevant financial relationships with ineligible companies to disclose.
Dahui Qin, MD & PhD has no relevant financial relationships with ineligible companies to disclose.
Unlabeled and Investigational Usage
The opinions expressed in this accredited continuing education activity are those of the faculty, and do not represent those of the Academy or Florida Society of Pathologists. This educational activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information. This activity may contain discussion of unlabeled/investigational usage.
Privacy